Steward WP - Search Results

1

Weekly oral 4-demethoxydaunorubicin in patients with relapsed low grade non-Hodgkin's lymphoma.

Steward WP, Smith DB, Crowther D. Steward WP, et al. Ann Oncol. 1991 Sep;2(8):605-6. doi: 10.1093/oxfordjournals.annonc.a058028. Ann Oncol. 1991. PMID: 1793728 Free article. Clinical Trial. No abstract available.

2

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

Cowan RA, Jones M, Harris M, Steward WP, Radford JA, Wagstaff J, Deakin DP, Crowther D. Cowan RA, et al. Among authors: steward wp. Br J Cancer. 1989 Feb;59(2):276-82. doi: 10.1038/bjc.1989.57. Br J Cancer. 1989. PMID: 2930692 Free PMC article.

3

Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.

Steward WP, Scarffe JH, Bonnem E, Crowther D. Steward WP, et al. Int J Cell Cloning. 1990 Jan;8 Suppl 1:335-46. doi: 10.1002/stem.5530080731. Int J Cell Cloning. 1990. PMID: 2182743 Free article.

4

Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor.

Steward WP, Scarffe JH, Austin R, Crowther D. Steward WP, et al. Behring Inst Mitt. 1988 Aug;(83):324-6. Behring Inst Mitt. 1988. PMID: 3071348

5

Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors.

Steward WP, Crowther D, McWilliam LJ, Jones JM, Deakin DP, Todd ID, Blackledge G, Wagstaff J, Scarffe JH, Harris M. Steward WP, et al. Cancer. 1988 Feb 1;61(3):441-7. doi: 10.1002/1097-0142(19880201)61:3<441::aid-cncr2820610306>3.0.co;2-n. Cancer. 1988. PMID: 3338014 Clinical Trial.

6

A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.

Steward WP, Todd ID, Harris M, Jones JM, Blackledge G, Wagstaff J, Anderson H, Wilkinson PM, Crowther D. Steward WP, et al. Eur J Cancer Clin Oncol. 1984 Jul;20(7):881-9. doi: 10.1016/0277-5379(84)90159-7. Eur J Cancer Clin Oncol. 1984. PMID: 6547675

7

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Steward WP, Verweij J, Somers R, Spooner D, Kerbrat P, Clavel M, Crowther D, Rouesse J, Tursz T, Tueni E, et al. Steward WP, et al. J Clin Oncol. 1993 Jan;11(1):15-21. doi: 10.1200/JCO.1993.11.1.15. J Clin Oncol. 1993. PMID: 8418226

8

Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress.

Price CG, Rohatiner AZ, Steward W, Deakin D, Bailey N, Norton A, Blackledge G, Crowther D, Lister TA. Price CG, et al. Ann Oncol. 1991 Feb;2 Suppl 2:141-5. doi: 10.1007/978-1-4899-7305-4_22. Ann Oncol. 1991. PMID: 2049311 Free article. Clinical Trial.

9

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.

Steward WP, Scarffe JH, Dirix LY, Chang J, Radford JA, Bonnem E, Crowther D. Steward WP, et al. Br J Cancer. 1990 May;61(5):749-54. doi: 10.1038/bjc.1990.167. Br J Cancer. 1990. PMID: 1692472 Free PMC article.

10

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.

Steward WP, Scarffe JH, Austin R, Bonnem E, Thatcher N, Morgenstern G, Crowther D. Steward WP, et al. Br J Cancer. 1989 Jan;59(1):142-5. doi: 10.1038/bjc.1989.28. Br J Cancer. 1989. PMID: 2667607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters